Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 13, 2012 - Issue 7
Submit an article Journal homepage
521
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease

Paschalis SteiropoulosDemocritus University of Thrace, Department of Pulmonology, Alexandroupolis, [email protected]
, MD,
Nikolaos PapanasDemocritus University of Thrace, Second Department of Internal Medicine, Alexandroupolis, Greece
, MD,
Evangelia NenaDemocritus University of Thrace, Department of Pulmonology, Alexandroupolis, [email protected]
, MD &
Demosthenes BourosDemocritus University of Thrace, Department of Pulmonology, Alexandroupolis, [email protected]
, MD
Pages 1015-1029 | Published online: 04 Apr 2012

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Paschalis Steiropoulos, Kostas Archontogeorgis, Evangelia Nena & Demosthenes Bouros. (2014) New developments in the management of COPD: clinical utility of indacaterol 75 μg. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 1-7.
Read now

Articles from other publishers (3)

Gao Zhen, Liu Yingying & Dong Jingcheng. (2022) Drug Therapies for COPD: A Bibliometric Review From 1980 to 2021. Frontiers in Pharmacology 13.
Crossref
Ce Yi, Gang Xing, Siqi Wang, Xiaoran Li, Yichuang Liu, Jinyan Li, Bin Lin, Anthony Yiu-Ho Woo, Yuyang Zhang, Li Pan & Maosheng Cheng. (2020) Design, synthesis and biological evaluation of 8-(2-amino-1-hydroxyethyl)-6-hydroxy-1,4-benzoxazine-3(4H)-one derivatives as potent β2-adrenoceptor agonists. Bioorganic & Medicinal Chemistry 28:1, pages 115178.
Crossref
P. Steiropoulos, N. Papanas, E. Nena, M. Xanthoudaki, T. Goula, M. Froudarakis, E. Pita, E. Maltezos & D. Bouros. (2012) Mean Platelet Volume and Platelet Distribution Width in Patients With Chronic Obstructive Pulmonary Disease. Angiology 64:7, pages 535-539.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.